OCA
Octagon Capital Advisors’s Taysha Gene Therapies TSHA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.1M | Buy |
12,592,500
+1,892,500
| +18% | +$4.37M | 6.38% | 4 |
|
|
2025
Q1 | $14.9M | Buy |
10,700,000
+250,000
| +2% | +$348K | 2.88% | 12 |
|
|
2024
Q4 | $18.1M | Buy |
10,450,000
+5,877,778
| +129% | +$10.2M | 2.97% | 12 |
|
|
2024
Q3 | $9.19M | Hold |
4,572,222
| – | – | 1.43% | 18 |
|
|
2024
Q2 | $10.2M | Buy |
4,572,222
+1,542,222
| +51% | +$3.45M | 1.61% | 15 |
|
|
2024
Q1 | $8.7M | Buy |
+3,030,000
| New | +$8.7M | 1.04% | 27 |
|
|
2023
Q4 | – | Sell |
-2,777,778
| Closed | -$8.78M | – | 42 |
|
|
2023
Q3 | $8.78M | Buy |
+2,777,778
| New | +$8.78M | 1.35% | 15 |
|
|
2021
Q3 | – | Sell |
-320,440
| Closed | -$6.79M | – | 35 |
|
|
2021
Q2 | $6.79M | Hold |
320,440
| – | – | 1.41% | 20 |
|
|
2021
Q1 | $6.51M | Hold |
320,440
| – | – | 2.45% | 17 |
|
|
2020
Q4 | $8.5M | Buy |
+320,440
| New | +$8.5M | 2.95% | 14 |
|